USA: A large US-based phase III clinical trial has shown that proton radiotherapy offers a meaningful survival advantage and ...
MedPage Today on MSN
Proton Therapy for Oropharyngeal Cancer Makes a Case for Standard of Care
Proton radiotherapy (RT) for oropharyngeal cancer matched conventional photon therapy for slowing disease progression and led ...
Intensity-modulated radiation therapy (IMRT) should be the preferred choice when treating patients with locally advanced non-small cell lung cancer (NSCLC), as it reduces radiation exposure to the ...
For patients with stage III or IV oropharyngeal cancer, intensity-modulated proton therapy (IMPT) is noninferior to intensity ...
Please provide your email address to receive an email when new articles are posted on . Men with low- or intermediate-risk prostate cancer achieved similar quality-of-life outcomes whether they ...
Intraoral photobiomodulation therapy reduced severe oral mucositis and other adverse effects of radiation therapy in patients with HNC.
According to preliminary data from a multi-institution Phase III trial led by researchers at The University of Texas MD Anderson Cancer Center, intensity modulated proton therapy (IMPT) achieved ...
Patient-reported outcomes (PROs) in the C-POST trial of adjuvant cemiplimab (cemi) vs placebo (pbo) for high-risk cutaneous squamous cell carcinoma (CSCC). Efficacy analysis of neoadjuvant PD-1 ...
Oral cancer involves malignant growths or tumors that can occur anywhere in the mouth or the throat. Doctors sometimes recommend radiation therapy to treat it, which involves doses of radiation to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results